Your session is about to expire
← Back to Search
Time-Restricted Eating for Coronary Heart Disease (TREat-CR Trial)
TREat-CR Trial Summary
This trial will study the feasibility and safety of using a time-restricted eating diet during cardiac rehabilitation, and if it has any benefits compared to cardiac rehabilitation alone.
TREat-CR Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTREat-CR Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.TREat-CR Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You eat within a time period of less than 12 hours each day, or you consistently eat fewer than 3 meals each day for the past 3 months.You have a history of an eating disorder that you have reported yourself.I am underweight or show signs of severe weight loss.You work at night or have a schedule that changes regularly.My participation helps maintain gender balance in the study.You cannot do a test to check how well your heart and lungs are working, or you have reasons not to do this test.You have type 1 diabetes.I have type 2 diabetes and need insulin injections.I am eligible for outpatient cardiac rehab for coronary artery disease.
- Group 1: Standard cardiac rehabilitation + TRE
- Group 2: Standard cardiac rehabilitation
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the purpose of this experiment?
"This 16 week clinical investigation seeks to evaluate cardio-respiratory fitness by measuring peak oxygen consumption (VO2peak). Secondary endpoints include self-reported nutritional adverse events, hemoglobin A1c levels determined via a blood draw, and the Seattle Angina Questionnaire score."
Are any new volunteers being accepted for this clinical experiment?
"Unfortunately, the information on clinicaltrials.gov reports that this trial has ended recruitment and is no longer seeking participants. The study was first listed on July 11th 2022 but last revised on July 15th 2022. Nevertheless, there are 573 other trials actively recruiting patients right now."
Share this study with friends
Copy Link
Messenger